Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

ClinicalTrials.gov ID: NCT00248170

Public ClinicalTrials.gov record NCT00248170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00248170
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
4,172 participants

Conditions and interventions

Conditions

Interventions

  • Letrozole Drug
  • Anastrozole Drug

Drug

Eligibility (public fields only)

Age range
33 Years to 96 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2005
Primary completion
Aug 31, 2014
Completion
Aug 31, 2014
Last update posted
Apr 18, 2016

2005 – 2014

United States locations

U.S. sites
42
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Birmingham Hematology and Oncology Associates Birmingham Alabama 35205
Comprehensive Cancer Institute Huntsville Alabama 35801
Northern Arizona Hematology/Oncology Associates, P.C. Flagstaff Arizona 86001
Oncology & Hematology Associates, PC New London Connecticut 06320
Florida Cancer Specialists Fort Meyers Florida 33901
Sarah Cannon Research Institute Jacksonville Florida 32256
Cancer Centers of Florida PA Ocoee Florida 34761
Florida Cancer Institute Orlando Florida 32804
Gulfcoast Oncology Associates St. Petersburg Florida 33705
University Cancer & Blood Center, LLC Athens Georgia 30607
Central Indiana Cancer Centers Indianapolis Indiana 46227
Kansas City Cancer Center Overland Park Kansas 66210
Wichita Community Clinical Oncology Program Wichita Kansas 67214
Center for Cancer & Blood Disorders Bethesda Maryland 20817
St. Louis Cancer & Breast Institute St Louis Missouri 63141
New York Oncology Hematology, P.C. NYOH Latham Troy New York 12180
Raleigh Hematology Oncology Associates Cary North Carolina 27511
Aultman Cancer Center Canton Ohio 44710
Sarah Cannon Oncology Hematology Care, Inc Cincinnati Ohio 45242
Oncology Associates of Oregon, PC Eugene Oregon 97401-8122
Medical Oncology Associates of Wyorning Valley, PC Kingston Pennsylvania 18704
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Tennessee 37404
Sarah Cannon Research Institute Nashville Tennessee 37203
Texas Oncology, P.A. Bedford Texas 76022
Center for Oncology Research and Treatment, PA Dallas Texas 75230
Texas Cancer Center ( Medical City Dallas Hospital) Dallas Texas 75230
Texas Oncology Presbyterian Hospital Dallas Texas 75246
Texas Oncology Sammons Cancer Center Dallas Texas 75246
Texas Oncology Texas Oncology PA Dallas Texas 75251
Texas Cancer Center Denton Denton Texas 76210
El Paso Cancer Treatment Ctr-East El Paso Texas 79915
Texas Oncology, P.A. Fort Worth Texas 76104
San Antonio Tumor and Blood Clinic Fredericksburg Texas 78624
MD Anderson Cancer Center/University of Texas Houston Texas 77030
Longview Cancer Center Longview Texas 75601
South Texas Cancer Center- McAllen McAllen Texas 78503
Allison Cancer Center Midland Texas 79701-5946
Texas Cancer Center- Sherman Sherman Texas 75090-0504
Tyler Cancer Center Tyler Texas 75702
Waco Cancer and Research Center Waco Texas 76712
Virginia Cancer Specialists, PC Fairfax Virginia 22031
Northwest Cancer Specialists, P.C. Vancover Washington 98664

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 217 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00248170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00248170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →